|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
4.51/14.80
|
企业价值
83.12B
|
资产负债 |
每股账面净值
88.75
|
现金流量 |
现金流量率
0.05
|
损益表 |
收益
19.37B
|
每股收益
65.90
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/19 14:14 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2023 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business. |